Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply to Sfeir

Johann Motsch1, Katherine Young2, Michelle L Brown2

  • 1Universitätsklinikum Heidelberg, Heidelberg, Germany.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|July 8, 2020
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Reward and Heightened Threat Neural Activity are Both Associated with Heightened Anhedonia: A Transdiagnostic Perspective.

Research square·2026
Same author

Long-term trends in ceftolozane-tazobactam susceptibility among gram-negative pathogens in the United States: a nine-year SMART analysis (2016-2024).

JAC-antimicrobial resistance·2026
Same author

Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections.

The Pediatric infectious disease journal·2026
Same author

Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024.

Frontiers in cellular and infection microbiology·2026
Same author

Determining the Activity of Imipenem/Relebactam Plus Aztreonam Against Constitutive <i>Pseudomonas</i>-Derived Cephalosporinase- and Metallo-β-Lactamase-Producing <i>Pseudomonas aeruginosa</i> in a Hollow Fiber Infection Model.

Open forum infectious diseases·2026
Same author

Diagnostic performance of β-(1→3)-D-glucan, two <i>Candida</i> antigen, and five anti-<i>Candida</i> antibody assays in ICU patients with sepsis and high risk for invasive candidiasis: a secondary endpoint of the CandiSep randomized clinical trial.

Journal of clinical microbiology·2026